TagCOSM 2019
The Role of Information Theory in Medicine
Jay Richards interviews Matt Scholz, Founder & CEO of Oisín Biotechnologies about the challenges and promises of the information theory of biotechJay Richards interviews Matt Scholz, Founder & CEO of Oisín Biotechnologies about the challenges and promises of the information theory of biotech. Besides the regulatory environment, Scholz believes that one of the biggest impediments to breakthroughs in medicine is the ability to empower the patient. Strangely, the one person who has no say in healthcare is the patient who ought to be “the arbiter of what goes into their body and not just be subject to the whims of the system.” Matthew Scholz is Immusoft’s founder and served as the company’s Chief Executive Officer from 2009 through 2017. Immusoft’s inflection point as a company came when Matthew conceived how a research system developed by Nobel Laureate and former President of Read More ›
Can Crypto Reverse the Tech Decline?
Listen to a 2019 COSM panel on crypto and the blockchainFor today’s featured COSM video, enjoy this panel from the 2019 conference on cryptocurrencies, the blockchain, and its potential for the tech world. The panel explores the future of cryptocurrency/blockchain technologies, and considers the implications for global money, global security, and internet architecture. We’ve been sharing a number of lectures from past COSM conferences. This video is just one of many you can find at the Bradley Center’s YouTube page. There you’ll find several lectures, interviews, and panels dealing with issues that range from economics, Big Tech, and artificial intelligence. Notable speakers include 2022 Kyoto Prize winner Carver Mead, venture capitalist Peter Thiel, and George Gilder, co-founder of Discovery Institute and author of Life After Capitalism: The Meaning of Wealth, the Future of the Economy, and Read More ›
Gene Therapy: IT Meets Medicine, But Who Is In Charge?
A biotechnology CEO would like to see patients have more power in determining advanced treatmentsJay Richards talked recently with Matt Scholz, Founder & CEO of Oisín Biotechnologies, about the challenges and promises of the information theory of biotech, especially as related to medicine: The panel in which Scholz participated at COSM 2019 focused on how artificial intelligence can make a difference in medicine: From the interview: Jay Richards: So how would you distill this panel? It was you and Babak Parviz, formerly of Google Glass and now from Amazon (and formerly Google Glass) and Lindy Fishburne, who’s on the funding side of information technology and biology. Matt Scholz: The panel was put together ranging from the computational side of it to the actual therapeutic side and finance. So I think that made it a Read More ›
